Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
ConclusionsWell-established and clinically feasible blood biomarkers can guide individual treatment choice. Real-world validation of the rule identified in this post hoc analysis is merited.Clinical Trial RegistrationNCT01061736, NCT02332590, NCT01709578, NCT01768572.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Arthritis | Clinical Trials | Humira | Learning | Rheumatoid Arthritis | Rheumatology | Training | Universities & Medical Training